APA (7th ed.) Citation

AE, C., V, P., P, I., KA, T., D, T., A, D., . . . AG, T. (2026). Dalbavancin for infective endocarditis: A systematic review of effectiveness, safety, and dosing. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 45(4), 931. https://doi.org/10.1007/s10096-026-05434-3

Chicago Style (17th ed.) Citation

AE, Chaldoupis, et al. "Dalbavancin for Infective Endocarditis: A Systematic Review of Effectiveness, Safety, and Dosing." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 45, no. 4 (2026): 931. https://doi.org/10.1007/s10096-026-05434-3.

MLA (9th ed.) Citation

AE, Chaldoupis, et al. "Dalbavancin for Infective Endocarditis: A Systematic Review of Effectiveness, Safety, and Dosing." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 45, no. 4, 2026, p. 931, https://doi.org/10.1007/s10096-026-05434-3.